<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Many patients survive aneurysmal SAH with minimal neurological deficits, but are at risk for developing further neurological insult from <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> resulting from <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Nimodipine has proven to be effective in preventing this complication in a majority of patients studied, with <z:hpo ids='HP_0002615'>hypotension</z:hpo> the most severe adverse effect </plain></SENT>
<SENT sid="2" pm="."><plain>Nimodipine alone, or in combination with other methods of therapy, may significantly improve the neurological outcome in this select patient population </plain></SENT>
</text></document>